Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.

R. E. Champlin, S. D. Nimer, D. Oette, D. W. Golde

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.'. Together they form a unique fingerprint.